Central retinal artery occlusion and optic neuropathy secondary to platelet rich plasma injection: a case report

Maslan, Norashikin; Halim, Wan Haslina Wan Abdul; Din, Norshamsiah Md; Tang, Seng Fai

doi:10.18240/ijo.2021.06.23

Cited by 3 publications

(5 citation statements)

References 10 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In other PRP case series, seven cases of unilateral vision loss or impairment after PRP injection had been reported outside of this review. Unfortunately, the details of PRP composition, preparation, and injection techniques were not available 33–35 . Similar to filler‐induced vascular occlusion (FIVO), the glabellar remained the most vulnerable area because of its limited collateral circulation from supratrochlear and supraorbital arteries.…”

Section: Resultsmentioning

confidence: 99%

“…Unfortunately, the details of PRP composition, preparation, and injection techniques were not available. 33 , 34 , 35 Similar to filler‐induced vascular occlusion (FIVO), the glabellar remained the most vulnerable area because of its limited collateral circulation from supratrochlear and supraorbital arteries. Visible loss or impairment is rare but has a grave prognosis.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Use of platelet rich plasma for skin rejuvenation

Phoebe,

Lee,

Chan

et al. 2024

Skin Research and Technology

View full text Add to dashboard Cite

ObjectivePlatelet‐rich plasma (PRP) is recognized as a safe and effective therapy for regenerative skin healing and rejuvenation, utilizing autologous blood enriched with various growth factors. This review aims to assess the efficacy of PRP treatments for skin rejuvenation.MethodsKeywords such as “platelet‐rich plasma,” “rejuvenation,” “skin aging,” and “wrinkles” were queried on Ovid, PubMed, and MEDLINE to identify pertinent studies on PRP treatment for skin rejuvenation.ResultsAnalysis revealed that PRP treatment led to significant enhancements in multiple facial parameters after one to three sessions. Improvements were noted in skin pore size, texture, wrinkle reduction, pigmented spots, collagen density, hyaluronic acid levels, and protection against ultraviolet damage. Combining PRP with hyaluronic acid demonstrated a synergistic effect, particularly enhancing skin elasticity in patients with lower body mass index and firmness in individuals aged 50s and 60s. Incorporating both physical and biometric data for assessment proved superior to relying solely on physical observations for evaluating subtle skin quality and structural changes.ConclusionThis study underscores the efficacy of PRP monotherapy for skin rejuvenation and emphasizes the necessity of standardizing PRP preparation protocols in future investigations. Heightened awareness and advancements in technology have contributed to the emergence of higher‐quality, less biased studies supporting PRP as a reliable and safe therapeutic option for skin rejuvenation.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Use of platelet rich plasma for skin rejuvenation

Phoebe,

Lee,

Chan

et al. 2024

Skin Research and Technology

View full text Add to dashboard Cite

show abstract

“…Reports of unilateral vision loss or impairment after PRP injection total 7 cases (Table 1). [2][3][4][5] All 7 patients had signs of arterial occlusion or ischemia on retinal examination or imaging (see Supplemental Digital Content 1, Table S1, http://links.lww.com/DSS/B52). Indications for PRP injections included skin rejuvenation (6 cases) and temporomandibular joint (TMJ) disorder (1 case).…”

mentioning

confidence: 99%

“…Indications for PRP injections included skin rejuvenation (6 cases) and temporomandibular joint (TMJ) disorder (1 case). Sites of injection associated with vision loss included glabella (5), forehead (2), lateral canthus (1), nasolabial fold (1), and the TMJ (1). In 5 cases, vision loss occurred immediately after injection.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Vision Loss After Platelet-Rich Plasma Injection: A Systematic Review

Weiß

2022

View full text Add to dashboard Cite

show abstract

Efficacy and safety of platelet-rich plasma for acute nonarteritic anterior ischemic optic neuropathy: a prospective cohort study

Jin,

Fu,

et al. 2024

Front. Med.

View full text Add to dashboard Cite

BackgroundAs the most common acute optic neuropathy in older patients, nonarteritic anterior ischemic optic neuropathy (NAION) presents with varying degrees of visual acuity loss and visual field defect. However, there is no generally accepted treatment for NAION.ObjectivesTo evaluate the efficacy and safety of platelet-rich plasma (PRP) for patients with acute NAION within 2 months.DesignA prospective, nonrandomized controlled trial.MethodsTwenty-five eyes of 25 patients were enrolled. Of them, 13 received anisodine hydrobromide and butylphthalide-sodium chloride injection continuously for 10 days as basic treatment in the control group, and 12 received two tenon capsule injections of PRP on a 10 days interval as an additional treatment in the PRP group. We compared the best-corrected visual acuity (BCVA) and capillary perfusion density (CPD) of radial peripapillary capillaries and the moth-eaten eara of the peripapillary superficial capillary plexus and deep capillary plexus at 1 day (D1) before the first PRP treatment and 7 days (D7), 14 days (D14), and 30 days (D30) after the first PRP injection. Ocular and systemic adverse effects were assessed.ResultsIn the PRP group, a better BCVA occurred at D30 (adjusted p = 0.005, compared with D1, recovered from 0.67 ± 0.59 to 0.43 ± 0.59), and a significant improvement in CPD was observed at D30 (adjusted p < 0.001, p = 0.027, p = 0.027, compared with D1, D7, D14, in sequence, the value was 35.97 ± 4.65, 38.73 ± 4.61, 39.05 ± 5.26, 42.71 ± 4.72, respectively). CPD at D7 in the PRP group was better than that in the control group (p = 0.043). However, neither BCVA nor the moth-eaten area index were significantly different (all p > 0.5) between the two groups. The main adverse effect was local discomfort resolved within 1 week, and no other systemic adverse events occurred.ConclusionTenon capsule injection of PRP was a safe treatment for AION and could improve capillary perfusion of the optic nerve head and might be helpful in increasing short-term vision in patients with acute NAION.

show abstract

Central retinal artery occlusion and optic neuropathy secondary to platelet rich plasma injection: a case report

Cited by 3 publications

References 10 publications

Use of platelet rich plasma for skin rejuvenation

Use of platelet rich plasma for skin rejuvenation

Vision Loss After Platelet-Rich Plasma Injection: A Systematic Review

Efficacy and safety of platelet-rich plasma for acute nonarteritic anterior ischemic optic neuropathy: a prospective cohort study

Contact Info

Product

Resources

About